Yang C, Wang W, Deng P, Wang X, Zhu L, Zhao L, Li C, Gao H
2 As shown in Table 1, there are several important reasons why oral options such as SGLT2 inhibitors or DPP-4 inhibitors should be considered
The Synergy When combined, these actives reinforce one another : Berberine + Chromium powerful insulin regulation and appetite control L-Carnitine + Citrus Aurantium accelerated fat mobilisation and energy Cinnamon ties it all together, stabilising post-meal sugar levels The result: less fat storage, steady blood sugar, reduced cravings, and improved focus and energy all essential for sustainable weight loss
They can identify underlying conditions like Cushing's syndrome, hypothyroidism, or polycystic ovary syndrome that require specialized treatment alongside GLP-1 therapy
Practitioners should keep in mind patients weight, age, and dosing of the methylene blue and the other medications or supplements the patient may be using